| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,¶
,,
,¶
Divisions of
*
Emergency Medicine and
Immunology, Children’s Hospital Medical Center, Cincinnati, OH 45229;
Division of Immunology, Department of Internal Medicine and
Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH 45267;
¶ Veterans Administration Medical Center, Cincinnati, OH 45220; and
|| Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, U.S. Department of Agriculture, Beltsville, MD 20705
We evaluated whether IL-4, a cytokine critical for inducing allergic responses, also contributes to the effector phase of allergy. Pretreatment of mice with IL-4 or the related cytokine, IL-13, rapidly and dramatically increased the severity of anaphylaxis induced by cross-linking Fc
RI or Fc
RIII. This effect was inhibited by endogenously produced IFN-, was T cell-, B cell-, and common -chain-independent, and required IL-4R
and Stat6. IL-4R signaling also enhanced anaphylaxis in mice infected with a nematode parasite that stimulates IL-4/IL-13 production. IL-4 exacerbated anaphylaxis by acting synergistically with vasoactive mediators to increase vascular permeability. Synergy between IL-4 and vasoactive mediators during the effector phase of allergic inflammation may both contribute to allergic immunopathology and enhance protective immunity against gastrointestinal worms.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  E. E. Forbes, K. Groschwitz, J. P. Abonia, E. B. Brandt, E. Cohen, C. Blanchard, R. Ahrens, L. Seidu, A. McKenzie, R. Strait, et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity J. Exp. Med., April 14, 2008; 205(4): 897 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Audicana and M. W. Kennedy Anisakis simplex: from Obscure Infectious Worm to Inducer of Immune Hypersensitivity Clin. Microbiol. Rev., April 1, 2008; 21(2): 360 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khodoun, C. Lewis, J.-Q. Yang, T. Orekov, C. Potter, T. Wynn, M. Mentink-Kane, G. K. Khurana Hershey, M. Wills-Karp, and F. D. Finkelman Differences in Expression, Affinity, and Function of Soluble (s)IL-4R{alpha} and sIL-13R{alpha}2 Suggest Opposite Effects on Allergic Responses J. Immunol., November 15, 2007; 179(10): 6429 - 6438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nieuwenhuizen, D. R. Herbert, A. L. Lopata, and F. Brombacher CD4+ T Cell-Specific Deletion of IL-4 Receptor {alpha} Prevents Ovalbumin-Induced Anaphylaxis by an IFN-{gamma}-Dependent Mechanism J. Immunol., September 1, 2007; 179(5): 2758 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Lin and J. A. Boyce IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells J. Immunol., October 15, 2005; 175(8): 5430 - 5438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Minami, Y. Yanagawa, K. Iwabuchi, N. Shinohara, T. Harabayashi, K. Nonomura, and K. Onoe Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions Blood, September 1, 2005; 106(5): 1685 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Knoops, J. Louahed, J. Van Snick, and J.-C. Renauld IL-9 Promotes but Is Not Necessary for Systemic Anaphylaxis J. Immunol., July 1, 2005; 175(1): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fairweather, S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, S. J.L. Gatewood, D. B. Njoku, and N. R. Rose Interferon-{gamma} Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-{beta}1, Interleukin-1{beta}, and Interleukin-4 in the Heart Am. J. Pathol., December 1, 2004; 165(6): 1883 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Mangan, R. E. Fallon, P. Smith, N. van Rooijen, A. N. McKenzie, and P. G. Fallon Helminth Infection Protects Mice from Anaphylaxis via IL-10-Producing B Cells J. Immunol., November 15, 2004; 173(10): 6346 - 6356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Khodoun, T. Orekhova, C. Potter, S. Morris, and F. D. Finkelman Basophils Initiate IL-4 Production during a Memory T-dependent Response J. Exp. Med., October 4, 2004; 200(7): 857 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Kelly-Welch, M. E. F. Melo, E. Smith, A. Q. Ford, C. Haudenschild, N. Noben-Trauth, and A. D. Keegan Complex Role of the IL-4 Receptor {alpha} in a Murine Model of Airway Inflammation: Expression of the IL-4 Receptor {alpha} on Nonlymphoid Cells of Bone Marrow Origin Contributes to Severity of Inflammation J. Immunol., April 1, 2004; 172(7): 4545 - 4555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Gillespie, R. R. DeMartino, J. Zhu, H. J. Chong, C. Ramirez, C. P. Shelburne, L. A. Bouton, D. P. Bailey, A. Gharse, P. Mirmonsef, et al. IL-10 Inhibits Fc{epsilon}RI Expression in Mouse Mast Cells J. Immunol., March 1, 2004; 172(5): 3181 - 3188. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
